1984
DOI: 10.1111/j.1475-097x.1984.tb00803.x
|View full text |Cite
|
Sign up to set email alerts
|

Walking capacity of patients with intermittent claudication during chronic antihypertensive treatment with metoprolol and methyldopa

Abstract: In a placebo-controlled double-blind crossover trial, the effect of a 3-week course of treatment with metoprolol (100-200 mg daily) and methyldopa (500-1000 mg daily) on walking capacity on a treadmill with increasing work load was studied in 14 hypertensive patients with intermittent claudication. The walking capacity was not affected by the antihypertensive treatment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1986
1986
2013
2013

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…RenalfunctoL stodiesshowed,aglome-ardiltrationrteof 19 ml/min 15 days after ingestion aad 12 ml/mm four mohal.ater effectve renal plasma flow rising firm 169 to 480 ml/min. The fila fion rose from 0 11 to 021.…”
Section: Case Reportmentioning
confidence: 96%
“…RenalfunctoL stodiesshowed,aglome-ardiltrationrteof 19 ml/min 15 days after ingestion aad 12 ml/mm four mohal.ater effectve renal plasma flow rising firm 169 to 480 ml/min. The fila fion rose from 0 11 to 021.…”
Section: Case Reportmentioning
confidence: 96%
“…Moreover, the studies included in this review were performed in Finland, 12,13) Denmark, 14,15) Belgium, 16,17) Israel, 18) and the USA. 16,19) Investigation of racial diŠerences and a-receptor sensitivity in patients with IC is necessary.…”
Section: Discussionmentioning
confidence: 99%